Vanguard Capital Management’s BlossomHill Therapeutics BLSM Stock Holding History
Bought
Maintained
Sold
Other funds holding BLSM
Vanguard Capital Management's BLSM Position: Q3 2026 in Review
Vanguard Capital Management opened a new position in BlossomHill Therapeutics (BLSM) in Q3 2026: 433,302 shares worth $8.08M. The stake represents ﹤0.01% of the portfolio and ranks #2884 among its holdings.
39 funds tracked by Wall St. Rank hold BLSM as of Q3 2026.
- Vanguard Capital Management held 433,302 shares of BlossomHill Therapeutics worth $8.08M as of Q3 2026.
- BlossomHill Therapeutics was a new Vanguard Capital Management position in Q3 2026.
- BlossomHill Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2884 holding.
- 39 funds tracked by Wall St. Rank held BlossomHill Therapeutics as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.